tiprankstipranks
Trending News
More News >
Cross Country Healthcare (CCRN)
:CCRN
Advertisement

Cross Country Healthcare (CCRN) AI Stock Analysis

Compare
254 Followers

Top Page

CC

Cross Country Healthcare

(NASDAQ:CCRN)

Rating:49Neutral
Price Target:
$13.00
▲(7.71%Upside)
The overall stock score is primarily impacted by financial performance challenges, particularly declining revenues and profitability. Technical analysis provides a neutral outlook with mixed signals, while valuation concerns arise from a negative P/E ratio and no dividend yield. These factors combine to suggest caution for potential investors.
Positive Factors
Acquisition Agreement
Aya Healthcare's acquisition of Cross Country for $18.61 per share in cash represents a 67% premium to the company’s closing price before the announcement.
Free Cash Flow
Free cash flow of $21.7 million in the quarter was a bright spot.
Negative Factors
Nurse and Allied Staffing Challenges
Nurse & Allied Staffing revenue declined 27% year-over-year and 6% quarter-over-quarter, indicating challenges in the largest part of the business.
Regulatory Uncertainty
Cross Country's shares were down 24% following the FTC's Second Request, reflecting increased uncertainty about the merger's completion.
Revenue Decline
Q1/25 revenue of $293.4 million came in lower than the consensus of $305.4 million, declining 23% year-over-year due to softer demand.

Cross Country Healthcare (CCRN) vs. SPDR S&P 500 ETF (SPY)

Cross Country Healthcare Business Overview & Revenue Model

Company DescriptionCross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
How the Company Makes MoneyCross Country Healthcare makes money primarily through the provision of staffing services to healthcare facilities. Its revenue model is based on the fees charged for placing healthcare professionals in temporary, travel, or permanent positions. The company earns a significant portion of its income from travel nurse staffing, where it supplies nurses to healthcare facilities on a short-term basis to fill gaps in staffing needs. Additionally, Cross Country Healthcare generates revenue from its managed services programs, which offer comprehensive workforce management solutions to healthcare systems, including recruitment, scheduling, and compliance services. Key revenue streams also include locum tenens staffing, which involves placing physicians and advanced practice providers on temporary assignments. Strategic partnerships with healthcare organizations and a broad network of qualified professionals are crucial factors contributing to the company's earnings.

Cross Country Healthcare Financial Statement Overview

Summary
Cross Country Healthcare faces significant challenges with declining revenues and profitability, as seen in the income statement. The balance sheet showcases moderate stability with low leverage, but declining asset levels raise concerns about liquidity. Cash flows exhibit volatility, indicating potential operational difficulties. Overall, the company must address its profitability issues to enhance financial health.
Income Statement
45
Neutral
The company's income statement shows a concerning trend with declining revenues and profitability. The TTM data reveals negative EBIT and net income, indicating operational and profitability challenges. The gross profit margin has decreased over the years, suggesting increased cost pressures or inefficiencies.
Balance Sheet
60
Neutral
The balance sheet exhibits moderate stability with a commendable equity ratio and manageable debt levels. However, the declining stockholders' equity and total assets over the recent periods indicate potential liquidity challenges. The company's debt-to-equity ratio remains low, mitigating financial risk to some extent.
Cash Flow
55
Neutral
Cash flow analysis reveals a decline in operating cash flows and free cash flow generation over time. Despite recent positive free cash flow, the operating cash flow to net income ratio indicates struggles in converting earnings to cash. The volatility in cash flows suggests potential liquidity issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.26B1.34B2.02B2.81B1.68B836.42M
Gross Profit246.55M274.25M450.41M627.69M375.00M202.73M
EBITDA-387.00K3.99M129.34M285.14M152.35M2.41M
Net Income-17.74M-14.56M72.63M188.46M132.00M-12.14M
Balance Sheet
Total Assets576.24M589.25M679.32M947.84M732.81M356.97M
Cash, Cash Equivalents and Short-Term Investments80.70M81.63M17.09M3.60M1.04M1.60M
Total Debt3.31M3.87M5.27M157.75M195.49M73.15M
Total Liabilities158.03M170.29M205.92M490.62M435.28M202.06M
Stockholders Equity418.21M418.96M473.39M457.22M297.53M154.38M
Cash Flow
Free Cash Flow111.40M111.40M234.52M125.26M-92.79M22.59M
Operating Cash Flow119.79M120.12M248.50M134.05M-85.62M27.20M
Investing Cash Flow-8.39M-8.71M-13.78M-43.87M-34.05M-4.62M
Financing Cash Flow-35.92M-46.85M-221.24M-87.60M119.09M-22.01M

Cross Country Healthcare Technical Analysis

Technical Analysis Sentiment
Negative
Last Price12.07
Price Trends
50DMA
13.35
Negative
100DMA
14.33
Negative
200DMA
14.63
Negative
Market Momentum
MACD
-0.32
Positive
RSI
28.54
Positive
STOCH
14.23
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCRN, the sentiment is Negative. The current price of 12.07 is below the 20-day moving average (MA) of 13.09, below the 50-day MA of 13.35, and below the 200-day MA of 14.63, indicating a bearish trend. The MACD of -0.32 indicates Positive momentum. The RSI at 28.54 is Positive, neither overbought nor oversold. The STOCH value of 14.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CCRN.

Cross Country Healthcare Risk Analysis

Cross Country Healthcare disclosed 36 risk factors in its most recent earnings report. Cross Country Healthcare reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Cross Country Healthcare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$986.59M23.878.37%3.71%1.32%
68
Neutral
$869.65M33.0711.28%30.04%43.47%
53
Neutral
$792.08M233.9142.49%9.05%
52
Neutral
$7.52B0.21-63.76%2.30%16.15%0.89%
49
Neutral
$395.69M-4.00%-29.16%-140.16%
49
Neutral
$46.08M-951.52%-0.70%-2.38%
AMAMN
49
Neutral
$810.10M18.62-21.08%-18.13%-215.78%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CCRN
Cross Country Healthcare
12.08
-3.11
-20.47%
AMN
AMN Healthcare Services
20.67
-35.62
-63.28%
HCSG
Healthcare Services
13.36
1.60
13.61%
MODV
ModivCare
3.30
-22.70
-87.31%
PNTG
Pennant Group
25.35
-2.04
-7.45%
AVAH
Aveanna Healthcare Holdings
4.07
0.39
10.60%

Cross Country Healthcare Corporate Events

M&A TransactionsFinancial Disclosures
Cross Country Healthcare Reports Q1 2025 Financial Results
Neutral
May 7, 2025

Cross Country Healthcare announced its financial results for the first quarter of 2025, showing a consolidated revenue of $293.4 million, which represents a 23% decrease year-over-year. Despite the decline in revenue, the company reported growth in its Homecare and Physician Staffing segments, with double-digit revenue increases. The company maintained a strong balance sheet with $81 million in cash and no debt as of March 31, 2025. The company is also in the process of a merger with Aya Healthcare, expected to be completed in the second half of the year.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 24, 2025